Your browser doesn't support javascript.
loading
MCT4 blockade increases the efficacy of immune checkpoint blockade.
Babl, Nathalie; Decking, Sonja-Maria; Voll, Florian; Althammer, Michael; Sala-Hojman, Ada; Ferretti, Roberta; Korf, Clarissa; Schmidl, Christian; Schmidleithner, Lisa; Nerb, Benedikt; Matos, Carina; Koehl, Gudrun E; Siska, Peter; Bruss, Christina; Kellermeier, Fabian; Dettmer, Katja; Oefner, Peter J; Wichland, Marvin; Ugele, Ines; Bohr, Christopher; Herr, Wolfgang; Ramaswamy, Shivapriya; Heinrich, Timo; Herhaus, Christian; Kreutz, Marina; Renner, Kathrin.
Afiliación
  • Babl N; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
  • Decking SM; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
  • Voll F; Department of Otorhinolaryngology, University Hospital Regensburg, Regensburg, Germany.
  • Althammer M; Leibniz Institute for Immunotherapy, Regensburg, Germany.
  • Sala-Hojman A; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
  • Ferretti R; Leibniz Institute for Immunotherapy, Regensburg, Germany.
  • Korf C; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
  • Schmidl C; Merck Healthcare KGaA, Darmstadt, Germany.
  • Schmidleithner L; EMD Serono Research and Development Institute, Inc, Billerica, Massachusetts, USA, an affiliate of Merck KGaA.
  • Nerb B; Department of Otorhinolaryngology, University Hospital Regensburg, Regensburg, Germany.
  • Matos C; Leibniz Institute for Immunotherapy, Regensburg, Germany.
  • Koehl GE; Leibniz Institute for Immunotherapy, Regensburg, Germany.
  • Siska P; Leibniz Institute for Immunotherapy, Regensburg, Germany.
  • Bruss C; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
  • Kellermeier F; Department of Surgery, University Hospital Regensburg, Regensburg, Germany.
  • Dettmer K; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
  • Oefner PJ; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
  • Wichland M; Department of Gynecology and Obstetrics, University Hospital Regensburg, Regensburg, Germany.
  • Ugele I; Institute of Functional Genomics, University of Regensburg, Regensburg, Germany.
  • Bohr C; Institute of Functional Genomics, University of Regensburg, Regensburg, Germany.
  • Herr W; Institute of Functional Genomics, University of Regensburg, Regensburg, Germany.
  • Ramaswamy S; Department of Otorhinolaryngology, University Hospital Regensburg, Regensburg, Germany.
  • Heinrich T; Department of Otorhinolaryngology, University Hospital Regensburg, Regensburg, Germany.
  • Herhaus C; Department of Otorhinolaryngology, University Hospital Regensburg, Regensburg, Germany.
  • Kreutz M; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany.
  • Renner K; EMD Serono Research and Development Institute, Inc, Billerica, Massachusetts, USA, an affiliate of Merck KGaA.
J Immunother Cancer ; 11(10)2023 10.
Article en En | MEDLINE | ID: mdl-37880183
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Inhibidores de Puntos de Control Inmunológico Límite: Animals / Humans Idioma: En Revista: J Immunother Cancer Año: 2023 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Inhibidores de Puntos de Control Inmunológico Límite: Animals / Humans Idioma: En Revista: J Immunother Cancer Año: 2023 Tipo del documento: Article País de afiliación: Alemania